All posts tagged "CORBEVAX"
-
238NEWSIndia’s Covid Vaccine Corbevax Gets WHO Emergency Use Listing Authorisation
Hyderabad: India’s COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in...
-
394NEWSCovishield, Covaxin & Corbevax: How Merck Silently Toiled to Add Feathers to India’s Covid Vaccination Feat
Merck is involved in B2B trade and helps top drug makers across India take their products from research and development (R&D) to...
-
529NEWSDespite DCGI Nod, Here’s Why Biological E’s Corbevax is Not Yet Available for Booster Shots
“How do we justify clearing a vaccine made on strains when the strain does not prevail anymore,” asked Dr J P Mulliyal,...
-
454NEWSCorbevax maker seeks emergency use approval as booster jab for adults vaccinated with Covishield, Covaxin
Biological E has submitted an application to India’s drug regulator seeking emergency use authorisation for its Covid vaccine Corbevax as a booster...
-
309NEWSGovt Panel Recommends Corbevax Use Among Kids Aged 5-12 Years Amid Covid Uptick
The vaccine by Biological E is currently being administered to children in the age group of 12-14 years The Subject Expert Committee...
-
751MUST KNOW12-14 year-olds to be given Corbevax vaccine: Registration, dosage gap and other details in 10 points
The COVID vaccination for children in the age group of 12-14 years will begin from tomorrow as the government has allowed the Corbevax...
-
379MUST KNOWCorbevax vaccine for kids: Everything you need to know about this Covid jab
Vaccination of children in the 12-14 year age group against the Covid-19 began on Wednesday. Biological E Limited’s Corbevax is being administered to children...
-
372NEWSBiological E seeks approval for Corbevax for 5-12 age group, know all about the Covid vaccine
The data for the approval has been submitted by the company to the Subject Expert Committee for beneficiaries between 5-12 years of...
-
255MUST KNOWCorbevax, Biological E’s COVID-19 Biological E’s Vaccine Receives Emergency Use Approval For 12-18 Age Group
With this, Corbevax became India’s third homegrown vaccine, to receive an emergency use approval in India for use in adolescents New Delhi: The...
-
445NEWS
DCGI grants emergency use authorisation to Corbevax for 12-18 year age group
This approval for Corbevax is likely to speed up the ongoing vaccination drive for children between 15 and 18 years of age,...
